We are a privately held specialty pharmaceutical company focused on developing and commercializing products with abuse deterrent features and benefits based on our novel, patent-protected abuse deterrent technology platform, SentryBond™.
Our management team brings decades of formulation and clinical development expertise, as well as unique commercial experience marketing and selling pain management products.